Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of the word "BASILEA" surrounded by an oval.
PIXEL COUNT ACCEPTABLE
YES
PIXEL COUNT
711 x 250
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Basilea Pharmaceutica AG
*STREET
Grenzacherstrasse 487
*CITY
Basel
*COUNTRY
Switzerland
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
4058
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY OF INCORPORATION
Switzerland
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
001
*IDENTIFICATION
Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of
infections and diseases and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for
scientific clinical use; diagnostic reagents for clinical or medical laboratory use
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
005
*IDENTIFICATION
Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of dermatological conditions, namely,
eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Pharmaceutical and veterinary products and preparations, namely, for the treatment and
prevention of infections caused by bacteria, fungi, viruses, and rheumatoid arthritis; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases,
disorders and conditions in the area of oncology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area
of gastroenterology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical
and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical and veterinary products and
preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical and veterinary products and preparations, namely, for the treatment
and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases,
disorders and conditions in the area of endocrinology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the
area of nephrology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical
and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of allergies; Pharmaceutical and veterinary products and
preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical and veterinary products and preparations, namely, for the
treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of
diseases, disorders and conditions in the area of anesthesiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the
area of rheumatology; diagnostic preparations for medical clinical purposes; clinical medical reagents; all of the aforesaid for prescription only
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
042
*IDENTIFICATION
Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and
preparations
FILING BASIS
SECTION 1(b)
ATTORNEY INFORMATION
NAME
Evan A. Raynes
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Symbus Law Group, LLC
STREET
1775 I Street, NW, Suite 1150
CITY
Washington
STATE
District of Columbia
COUNTRY
United States
ZIP/POSTAL CODE
20006
PHONE
202-258-0652
OTHER APPOINTED ATTORNEY
Janice Bader
CORRESPONDENCE INFORMATION
NAME
Evan A. Raynes
FIRM NAME
Symbus Law Group, LLC
STREET
1775 I Street, NW, Suite 1150
CITY
Washington
STATE
District of Columbia
COUNTRY
United States
ZIP/POSTAL CODE
20006
PHONE
202-258-0652
*EMAIL ADDRESS
eraynes@symbus.com; legalasst@symbus.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
FEE INFORMATION
APPLICATION FILING OPTION
TEAS RF
NUMBER OF CLASSES
3
APPLICATION FOR REGISTRATION PER CLASS
275
*TOTAL FEE DUE
825
*TOTAL FEE PAID
825
SIGNATURE INFORMATION
SIGNATURE
/Evan A. Raynes/
SIGNATORY'S NAME
Evan A. Raynes
SIGNATORY'S POSITION
Attorney of record, DC bar member
SIGNATORY'S PHONE NUMBER
202-258-0652
DATE SIGNED
09/27/2019
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:88633518
Filing Date:09/27/2019
To the Commissioner for Trademarks:
MARK: BASILEA (stylized and/or with design, see mark)
The literal element of the mark consists of BASILEA. The applicant is not claiming color as a feature of the mark. The mark consists of the word "BASILEA" surrounded by an oval.
The applicant, Basilea Pharmaceutica AG, a corporation of Switzerland, having an address of
Grenzacherstrasse 487
Basel 4058
Switzerland
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 001: Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of infections and diseases
and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for scientific clinical use;
diagnostic reagents for clinical or medical laboratory use
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 005: Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection,
warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of infections caused by
bacteria, fungi, viruses, and rheumatoid arthritis; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area
of oncology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical
and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical and veterinary products and
preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical and veterinary products and preparations, namely, for the
treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases,
disorders and conditions in the area of cardiology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area
of endocrinology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical and
veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical and veterinary products and
preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of allergies; Pharmaceutical and veterinary products and preparations, namely, for the
treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of
diseases, disorders and conditions in the area of psychiatry; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions
in the area of anesthesiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; diagnostic
preparations for medical clinical purposes; clinical medical reagents; all of the aforesaid for prescription only
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 042: Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The applicant hereby appoints Evan A. Raynes. Other appointed attorneys are Janice Bader. Evan A. Raynes of Symbus Law Group, LLC, is a member of the XX bar, admitted to the bar in XXXX, bar
membership no. XXX, and the attorney(s) is located at
1775 I Street, NW, Suite 1150
Washington, District of Columbia 20006
United States
202-258-0652(phone)
Evan A. Raynes submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current Correspondence Information:
Email Authorization: I authorize the USPTO to send email correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the
email address provided in this application. I understand that a valid email address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent
application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional
processing fee of $125 per international class of goods/services.
A fee payment in the amount of $825 has been submitted with the application, representing payment for 3 class(es).
Declaration
Declaration Signature
Signature: /Evan A. Raynes/ Date: 09/27/2019
Signatory's Name: Evan A. Raynes
Signatory's Position: Attorney of record, DC bar member
Payment Sale Number: 88633518
Payment Accounting Date: 09/27/2019
Serial Number: 88633518
Internet Transmission Date: Fri Sep 27 11:22:36 EDT 2019
TEAS Stamp: USPTO/BAS-XX.XX.XXX.XXX-2019092711223685
9274-88633518-6107a8f6fbd8e86628c2533235
97f5f36c876648897f54981a25982495790d9ca-
CC-22369755-20190927111848708180